fringe Inhibitors
Chemical inhibitors of Fringe can impede its function by targeting the Notch signaling pathway, which is integral to Fringe's role in modifying Notch receptor activity. Gamma-secretase inhibitors such as DAPT, LY411575, RO4929097, L-685,458, PF-03084014, Avagacestat, Semagacestat, Begacestat, DBZ, MK-0752, and E-2012 act by preventing the cleavage of Notch precursors, which is a necessary step for producing the active form of the Notch receptor. Since Fringe's activity is contingent on the presence of this active receptor, the inhibitors effectively reduce Fringe's ability to modulate the signaling. By halting the formation of active Notch, these chemicals ensure that Fringe lacks the substrate it needs to exert its biological effects, thereby functionally inhibiting it.
The mechanism of action of these inhibitors involves the binding to the active site of gamma-secretase or altering its conformation, which in turn blocks the enzyme's ability to process Notch precursors. This inhibition of gamma-secretase activity translates into a reduction in the amount of active Notch receptor available in the cell. Fringe, which acts on the Notch receptors to influence their interaction with other molecules and subsequent signal transduction, is left without its target. As a result, the signaling cascade that Fringe would normally influence is effectively inhibited. The specificity of these chemical inhibitors for the gamma-secretase helps to ensure that the impact on Fringe's activity is a direct consequence of the disruption of Notch receptor processing. Thus, the functional inhibition of Fringe by these chemicals is achieved through a precise blockade of the Notch receptor's activation process, which is a critical point of action for Fringe's biological role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT is a gamma-secretase inhibitor that can indirectly inhibit Fringe by preventing the cleavage of Notch, a substrate of gamma-secretase. Since Fringe modulates Notch receptor activity, inhibiting Notch processing effectively inhibits Fringe's ability to exert its effects on Notch signaling. | ||||||
Dibenzazepine (Deshydroxy LY 411575) | 209984-56-5 | sc-207554 sc-207554A | 2 mg 5 mg | $235.00 $260.00 | 4 | |
LY411575 serves as another gamma-secretase inhibitor. By blocking the gamma-secretase-mediated cleavage of Notch, it indirectly inhibits the function of Fringe by stopping the production of the active form of Notch that Fringe would otherwise modify. | ||||||
RO-4929097 | 847925-91-1 | sc-364602 sc-364602A | 10 mg 50 mg | $439.00 $1417.00 | 1 | |
RO4929097 is a gamma-secretase inhibitor that, similar to DAPT and LY411575, prevents the cleavage and activation of Notch receptors, thereby indirectly inhibiting Fringe's role in Notch signaling. | ||||||
L-685,458 | 292632-98-5 | sc-204042 sc-204042A | 1 mg 5 mg | $337.00 $1000.00 | 4 | |
L-685,458 is an inhibitor specific for gamma-secretase, which, by preventing the formation of active Notch, indirectly inhibits the action of Fringe on Notch signal modulation. | ||||||
PF-2545920 | 1292799-56-4 | sc-364355 sc-364355A | 5 mg 10 mg | $405.00 $555.00 | ||
PF-03084014, also known as Nirogacestat, is a gamma-secretase inhibitor that indirectly inhibits Fringe by stopping the production of active Notch, which is necessary for Fringe to exert its effect. | ||||||
BMS-708163 | 1146699-66-2 | sc-364444 sc-364444A | 10 mg 50 mg | $480.00 $1455.00 | 1 | |
Avagacestat is a gamma-secretase inhibitor that impedes the cleavage of Notch, thereby indirectly inhibiting Fringe by not allowing Notch to be presented in a form that Fringe can act upon. | ||||||
Semagacestat | 425386-60-3 | sc-364614 sc-364614A | 10 mg 50 mg | $350.00 $1200.00 | 1 | |
Semagacestat is a gamma-secretase inhibitor, which indirectly inhibits Fringe by reducing the availability of its substrate, active Notch receptor, through the inhibition of the Notch-producing enzyme. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $198.00 $473.00 | 6 | |
DBZ, or dibenzazepine, is a gamma-secretase inhibitor that prevents the proteolytic activation of Notch receptors, thereby indirectly inhibiting Fringe by hindering its ability to modify Notch signaling. | ||||||
MK-0752 | 471905-41-6 | sc-364534 sc-364534A | 10 mg 50 mg | $592.00 $1550.00 | ||
MK-0752 is a gamma-secretase inhibitor that indirectly inhibits Fringe by blocking the formation of the active Notch receptor, which is essential for Fringe to modulate Notch signaling. | ||||||